The history of Sildenafil presents a challenging picture for shareholders. While the initial introduction generated substantial gains, the lapse of its exclusive rights opened the avenue to off-brand alternatives, https://indexedbookmarks.com/story21548157/sildenafil-and-pharma-a-volatile-bet